Hemizygosity for the COP9 signalosome subunit gene, SGN3, in the Smith-Magenis syndrome.

Smith-Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome associated with an interstitial deletion of chromosome band 17p11.2. The critical region is extremely gene-rich and spans approximately 1.5-2.0 Mb of DNA. Here we report the localization and partial characterization of the gene for subunit 3 of the COP9 signalosome, SGN3. SGN3 maps to the distal portion of the SMS critical interval, between SREBF1 and cCI17-638. We assessed the potential effect of haploinsufficiency of SGN3 in SMS patient lymphoblastoid cell lines through transfection studies and western analysis. Our results indicate that the COP9 signalosome assembles properly in these cells and appears to have normal expression and a kinase function intact. However, because the role of the COP9 signalosome in embryogenesis or differentiation is still uncertain, we cannot rule out the involvement of this gene in the Smith-Magenis syndrome.

[1]  J. Lupski,et al.  Subunit 3 of the COP9 signal transduction complex is conserved from plants to humans and maps within the smith-magenis syndrome critical region in 17p11.2. , 1999, Genomics.

[2]  X. Deng,et al.  Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. , 1999, Trends in genetics : TIG.

[3]  D. Vance,et al.  Identification of three novel cDNAs for human phosphatidylethanolamine N-methyltransferase and localization of the human gene on chromosome 17p11.2. , 1999, Biochimica et biophysica acta.

[4]  E. Dykens,et al.  Distinctiveness and correlates of maladaptive behaviour in children and adolescents with Smith-Magenis syndrome. , 1998, Journal of intellectual disability research : JIDR.

[5]  W. Baumeister,et al.  A Subcomplex of the Proteasome Regulatory Particle Required for Ubiquitin-Conjugate Degradation and Related to the COP9-Signalosome and eIF3 , 1998, Cell.

[6]  Minami Matsui,et al.  The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex , 1998, Current Biology.

[7]  C. Morton,et al.  Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. , 1998, Science.

[8]  R. Kraft,et al.  A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Lupski,et al.  Genetic mapping refines DFNB3 to 17p11.2, suggests multiple alleles of DFNB3, and supports homology to the mouse model shaker-2. , 1998, American journal of human genetics.

[10]  F Greenberg,et al.  Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2). , 1998, American journal of medical genetics.

[11]  F. Greenberg,et al.  Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2). , 1998, American journal of medical genetics.

[12]  P. Patel,et al.  Gene for topoisomerase III maps within the Smith-Magenis syndrome critical region: analysis of cell-cycle distribution and radiation sensitivity. , 1998, American journal of medical genetics.

[13]  A. C. Chinault,et al.  Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome , 1997, Nature Genetics.

[14]  A. Thorburn,et al.  MAP kinase‐ and Rho‐dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells , 1997, The EMBO journal.

[15]  B. Finucane,et al.  Brief Report: Cognitive and Behavioral Profiles in Persons with Smith-Magenis Syndrome , 1997, Journal of autism and developmental disorders.

[16]  T. Maniatis,et al.  Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway , 1997, Cell.

[17]  P. Patel,et al.  Definition of the critical interval for Smith-Magenis syndrome. , 1997, Cytogenetics and cell genetics.

[18]  F Greenberg,et al.  Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. , 1996, American journal of human genetics.

[19]  C McCluggage,et al.  Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) , 1996, American journal of medical genetics.

[20]  H. Li,et al.  Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis (*) , 1996, The Journal of Biological Chemistry.

[21]  J. Lupski,et al.  The Smith-Magenis syndrome [del(17)p11.2]: Clinical review and molecular advances , 1996 .

[22]  Y. Nakamura,et al.  The human homologue of the murine Llglh gene (LLGL) maps within the Smith-Magenis syndrome region in 17p11.2. , 1996, Cytogenetics and cell genetics.

[23]  Z. Estrov,et al.  Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. , 1996, Leukemia.

[24]  P. Patel,et al.  Haploinsufficiency of cytosolic serine hydroxymethyltransferase in the Smith-Magenis syndrome. , 1995, American journal of human genetics.

[25]  H. Hobbs,et al.  Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. , 1995, Genomics.

[26]  L. Shaffer,et al.  The human homologue of the Drosophila melanogaster flightless-I gene (flil) maps within the Smith-Magenis microdeletion critical region in 17p11.2. , 1995, American journal of human genetics.

[27]  D. Pinkel,et al.  Physical mapping of chromosome 17 cosmids by fluorescence in situ hybridization and digital image analysis. , 1994, Genomics.

[28]  J C Sanford,et al.  Optimizing the biolistic process for different biological applications. , 1993, Methods in enzymology.

[29]  D. Ledbetter,et al.  Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17. , 1990, American journal of human genetics.

[30]  D. Ledbetter,et al.  Precise localization of NF1 to 17q11.2 by balanced translocation. , 1989, American journal of human genetics.